Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
June 27, 2020
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
Nidal Al-Huniti, Yan Feng, Jingyu Jerry Yu, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
December 9, 2024
Pharmacokinetics of Zilurgisertib With and Without Food from Single and Multiple Ascending Dose Phase 1 Studies in Healthy Adults
Yan-Ou Yang, Xiaohua Gong, Jay Getsy, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 12, 2019
Population Pharmacokinetics of Ipilimumab in Combination With Nivolumab in Patients With Advanced Solid Tumors
Kinjal Sanghavi, Jason Zhang, Xiaochen Zhao, et al.
Clinical Pharmacology and Therapeutics
|
June 19, 2025
Exposure-Response Relationships for Axatilimab in Patients with Chronic Graft-Versus-Host Disease
Yan-Ou Yang, Alina Volkova, Victor Sokolov, et al.
Journal of Clinical Pharmacology
|
November 25, 2014
Inhibitory effect of single and repeated doses of nilotinib on the pharmacokinetics of CYP3A substrate midazolam
Hefei Zhang, Jennifer Sheng, Jin H Ko, et al.
Clinical Pharmacokinetics
|
August 6, 2017
The Clinical Pharmacology of Elotuzumab
Chaitali Passey, Jennifer Sheng, Johanna Mora, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 12, 2019
Population Pharmacokinetics of Nivolumab in Combination With Ipilimumab in Patients With Advanced Malignancies
Jason Zhang, Kinjal Sanghavi, Jun Shen, et al.
Clinical Pharmacology and Therapeutics
|
January 13, 2018
Challenges and Opportunities With Oncology Drug Development in China
Gaurav Bajaj, Manish Gupta, Hwei-Gene Heidi Wang, et al.
Clinical Pharmacology in Drug Development
|
June 4, 2025
Effect of Itraconazole or Rifampin on Zilurgisertib Pharmacokinetics When Administered Orally in Healthy Participants
Yan-Ou Yang, Xiaohua Gong, Phillip Wang, et al.
AAPS Pharmscitech
|
January 18, 2014
Application of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: mechanistic investigation of food effect
Hefei Zhang, Binfeng Xia, Jennifer Sheng, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
CPT: Pharmacometrics & Systems Pharmacology
|
June 27, 2020
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
Nidal Al-Huniti, Yan Feng, Jingyu Jerry Yu, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
December 9, 2024
Pharmacokinetics of Zilurgisertib With and Without Food from Single and Multiple Ascending Dose Phase 1 Studies in Healthy Adults
Yan-Ou Yang, Xiaohua Gong, Jay Getsy, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 12, 2019
Population Pharmacokinetics of Ipilimumab in Combination With Nivolumab in Patients With Advanced Solid Tumors
Kinjal Sanghavi, Jason Zhang, Xiaochen Zhao, et al.
Clinical Pharmacology and Therapeutics
|
June 19, 2025
Exposure-Response Relationships for Axatilimab in Patients with Chronic Graft-Versus-Host Disease
Yan-Ou Yang, Alina Volkova, Victor Sokolov, et al.
Journal of Clinical Pharmacology
|
November 25, 2014
Inhibitory effect of single and repeated doses of nilotinib on the pharmacokinetics of CYP3A substrate midazolam
Hefei Zhang, Jennifer Sheng, Jin H Ko, et al.
Clinical Pharmacokinetics
|
August 6, 2017
The Clinical Pharmacology of Elotuzumab
Chaitali Passey, Jennifer Sheng, Johanna Mora, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 12, 2019
Population Pharmacokinetics of Nivolumab in Combination With Ipilimumab in Patients With Advanced Malignancies
Jason Zhang, Kinjal Sanghavi, Jun Shen, et al.
Clinical Pharmacology and Therapeutics
|
January 13, 2018
Challenges and Opportunities With Oncology Drug Development in China
Gaurav Bajaj, Manish Gupta, Hwei-Gene Heidi Wang, et al.
Clinical Pharmacology in Drug Development
|
June 4, 2025
Effect of Itraconazole or Rifampin on Zilurgisertib Pharmacokinetics When Administered Orally in Healthy Participants
Yan-Ou Yang, Xiaohua Gong, Phillip Wang, et al.
AAPS Pharmscitech
|
January 18, 2014
Application of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: mechanistic investigation of food effect
Hefei Zhang, Binfeng Xia, Jennifer Sheng, et al.
Page
of 3